This clinical overview details the latest evidence-based strategies for diagnosing and treating symptoms of benign prostatic hyperplasia in men.

Entadfi is a fixed-dose combination of finasteride, a 5α-reductase inhibitor, and tadalafil, a phosphodiesterase 5 (PDE5) inhibitor. The Food and Drug Administration (FDA) has approved Entadfi ...

Extracts of the berries of saw palmetto, a small palm tree native to the southeastern U.S., are used widely to treat benign prostatic hyperplasia (BPH). In this randomized trial conducted in ...

The purpose of this manuscript is to provideclinicians, health plan decision makers, and policymakers with highlights of key findings pertainingto our current understanding of the condition ofenlarged ...

There are many potential causes of BPH, but most experts agree that age and gender are the primary factors. A family history of BPH also increases your risk for an enlarged prostate. The healthcare ...

Dr. Robert Nadler answers the question: 'What Is Benign Prostatic Hyperplasia?' March 16, 2009 -- Question: What is benign prostatic hyperplasia (BPH), and how is BPH treated? Answer: BHP, or benign ...

ST. LOUIS — As many men get older, their prostate gland enlarges, which may squeeze the urethra and obstruct the flow of urine. Other risk factors for Benign Prostatic Hyperplasia (BPH) include family ...

In patients with benign prostatic hyperplasia (BPH), adherence to the Mediterranean diet (MedDiet) is associated with improved urinary function and reduced lower urinary tract symptoms (LUTS), ...

Improvement in urinary symptoms with better preservation of ejaculatory function seen with double-n technology. (HealthDay News) — For men with benign prostatic hyperplasia (BPH), transurethral ...